Terns Pharmaceuticals Inc (TERN) Event June 01, 2022, 20:15 UTC 11 1 comments (99% Neutral) Terns Pharmaceuticals, Inc. (TERN) Provides Update on Medicine for three of our programs Comment Full text
Caribou Biosciences Inc (CRBU) Event June 01, 2022, 20:14 UTC 11 1 comments (99% Neutral) Caribou Biosciences, Inc. (CRBU) Provides Update on participate for 30 days Comment Full text
Sana Biotechnology Inc (SANA) Event June 01, 2022, 20:14 UTC 12 1 comments (99% Positive) SANA BIOTECHNOLOGY, INC. (SANA) Announces Clinical Development Update Comment Full text
Repare Therapeutics Inc (RPTX) Event June 01, 2022, 20:01 UTC 12 1 comments (10% Negative) Repare Therapeutics Inc. (RPTX) Announces Delay in tumors Trials for areas of high unmet medical need Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment Comment Full text
Keros Therapeutics Inc (KROS) Event June 01, 2022, 20:01 UTC 11 1 comments (99% Neutral) Keros Therapeutics, Inc. (KROS) Announces Regulatory Update Comment Full text
Genmab (GMAB) Event June 01, 2022, 16:37 UTC 11 1 comments (98% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K) Comment Full text
AstraZeneca (AZN) Event June 01, 2022, 14:47 UTC 10 1 comments (99% Neutral) AstraZeneca (AZN) Files Form 6-K Comment Full text
AstraZeneca (AZN) Event June 01, 2022, 14:18 UTC 10 1 comments (99% Neutral) AstraZeneca (AZN) Files Form 6-K Comment Full text
Relmada Therapeutics Inc (RLMD) Event June 01, 2022, 13:22 UTC 11 1 comments (99% Neutral) RELMADA THERAPEUTICS, INC. (RLMD) Announces Regulatory Update Comment Full text
Alpine Immune Sciences Inc (was acquired Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) on 10/04/2024) (ALPN) Event June 01, 2022, 13:00 UTC 11 1 comments (10% Negative) ALPINE IMMUNE SCIENCES, INC. (ALPN) Announces Clinical Trial Timeline Adjustment Comment Full text